MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Senseonics Holdings, Inc. - Common Stock (NY:SENS)

6.260 UNCHANGED
Last Price Updated: 8:00 PM EST, Nov 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Senseonics Holdings, Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
Senseonics Holdings, Inc. Reports First Quarter 2026 Financial Results
From Senseonics Holdings, Inc.
Via GlobeNewswire
News headline image
Senseonics Announces Closing of $92 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
From Senseonics Holdings, Inc.
Via GlobeNewswire
News headline image
Senseonics Enters Into Amended Loan Agreement with Hercules to Increase Borrowing Capacity to $140 Million
From Senseonics Holdings, Inc.
Via GlobeNewswire
News headline image
Senseonics Holdings, Inc. Schedules First Quarter 2026 Earnings Release and Conference Call for May 7, 2026 at 4:30 P.M. Eastern Time
From Senseonics Holdings, Inc.
Via GlobeNewswire
News headline image
Senseonics Announces Pricing of $80 Million Public Offering of Common Stock and Pre-Funded Warrants
From Senseonics Holdings, Inc.
Via GlobeNewswire
News headline image
Senseonics Announces Commencement of $80 Million Public Offering of Common Stock and Pre-Funded Warrants
From Senseonics Holdings, Inc.
Via GlobeNewswire
News headline image
Senseonics Announces European Launch of Eversense® 365, The World’s First and Only One Year CGM System
From Senseonics Holdings, Inc.
Via GlobeNewswire
News headline image
First Ever Real-World Evidence of Eversense 365 Presented at ATTD Demonstrates Sustained Performance and Positive Impact Throughout One-Year of Wear
From Senseonics Holdings, Inc.
Via GlobeNewswire
News headline image
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
From Senseonics Holdings, Inc.
Via GlobeNewswire
News headline image
Sequel Med Tech and Senseonics Launch Transformative Combination of twiist™ and Eversense® 365
The integrated system is now being used in real-world care settings and is widely available for people with type 1 diabetes 
From Sequel Med Tech
Via GlobeNewswire
News headline image
Senseonics Receives European Approval for Eversense 365, World’s Longest-lasting Continuous Glucose Monitor
From Senseonics Holdings, Inc.
Via GlobeNewswire
News headline image
Senseonics Holdings, Inc. to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
From Senseonics Holdings, Inc.
Via GlobeNewswire
News headline image
Senseonics Announces Preliminary Unaudited Revenue for Fourth Quarter 2025 and Provides Business Update
From Senseonics Holdings, Inc.
Via GlobeNewswire
News headline image
Senseonics Announces First Commercial Patients Using Eversense 365 Continuous Glucose Monitor (CGM) with twiist™ Automated Insulin Delivery (AID) System
twiist™ becomes the first AID system compatible with Senseonics Eversense® 365 one-year CGM 
From Senseonics Holdings, Inc.
Via GlobeNewswire
News headline image
Eversense 365 Receives FDA Clearance: The World’s First One Year CGM
From Ascensia Diabetes Care
Via Business Wire
News headline image
Senseonics Holdings, Inc. Reports Second Quarter 2024 Financial Results
From Senseonics Holdings, Inc.
Via Business Wire
News headline image
Senseonics Holdings, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for August 8, 2024 at 4:30 P.M. Eastern Time
From Senseonics Holdings, Inc.
Via Business Wire
News headline image
Senseonics Holdings, Inc. Provides Business Update and Full Year 2024 Financial Outlook
From Senseonics Holdings, Inc.
Via Business Wire
News headline image
Senseonics Holdings, Inc. to Host Business Update and Analyst Event During the American Diabetes Association’s 84th Scientific Sessions
From Senseonics Holdings, Inc.
Via Business Wire
News headline image
Sidoti Events, LLC's Virtual June Small-Cap Conference
Via ACCESSWIRE
News headline image
Senseonics Holdings, Inc. to Participate in the Sidoti Small Cap Conference
From Senseonics Holdings, Inc.
Via Business Wire
News headline image
Senseonics Holdings, Inc. Reports First Quarter 2024 Financial Results
From Senseonics Holdings, Inc.
Via Business Wire
News headline image
Senseonics and Mercy Collaborate to Improve Diabetes Population Health Management
From Senseonics Holdings, Inc.
Via Business Wire
News headline image
Senseonics Partners with Rimidi to Develop Innovative Diabetes Solution
From Senseonics Holdings, Inc.
Via Business Wire
News headline image
Senseonics Holdings, Inc. to Participate in Upcoming Conferences
From Senseonics Holdings, Inc.
Via Business Wire
News headline image
Senseonics Holdings, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 13, 2024 at 4:30 P.M. Eastern Time
From Senseonics Holdings, Inc.
Via Business Wire
News headline image
Eversense® CGM System Receives iCGM Designation by the US FDA
From Senseonics Holdings, Inc.
Via Business Wire
News headline image
Senseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes
From Senseonics Holdings, Inc.
Via Business Wire
News headline image
Senseonics Holdings, Inc. to Participate in the Oppenheimer 34th Annual Healthcare MedTech and Services Conference
From Senseonics Holdings, Inc.
Via Business Wire
News headline image
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
From Senseonics Holdings, Inc.
Via Business Wire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story